Bioteque - Asset Resilience Ratio
Bioteque (4107) has an Asset Resilience Ratio of 11.51% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Bioteque debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2024)
This chart shows how Bioteque's Asset Resilience Ratio has changed over time. See what is Bioteque's book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Bioteque's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Bioteque market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$516.92 Million | 11.51% |
| Total Liquid Assets | NT$516.92 Million | 11.51% |
Asset Resilience Insights
- Moderate Liquidity: Bioteque has 11.51% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Bioteque Industry Peers by Asset Resilience Ratio
Compare Bioteque's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.08% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 5.07% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.23% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 43.09% |
Annual Asset Resilience Ratio for Bioteque (2006–2024)
The table below shows the annual Asset Resilience Ratio data for Bioteque.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.75% | NT$360.09 Million ≈ $11.34 Million |
NT$4.65 Billion ≈ $146.36 Million |
+3.19pp |
| 2023-12-31 | 4.56% | NT$210.72 Million ≈ $6.64 Million |
NT$4.62 Billion ≈ $145.57 Million |
-1.02pp |
| 2022-12-31 | 5.59% | NT$250.26 Million ≈ $7.88 Million |
NT$4.48 Billion ≈ $141.16 Million |
-5.80pp |
| 2021-12-31 | 11.38% | NT$439.50 Million ≈ $13.85 Million |
NT$3.86 Billion ≈ $121.64 Million |
+3.17pp |
| 2020-12-31 | 8.21% | NT$292.60 Million ≈ $9.22 Million |
NT$3.56 Billion ≈ $112.28 Million |
+2.14pp |
| 2019-12-31 | 6.07% | NT$178.63 Million ≈ $5.63 Million |
NT$2.94 Billion ≈ $92.64 Million |
-0.36pp |
| 2018-12-31 | 6.43% | NT$178.27 Million ≈ $5.62 Million |
NT$2.77 Billion ≈ $87.32 Million |
-0.24pp |
| 2017-12-31 | 6.67% | NT$174.98 Million ≈ $5.51 Million |
NT$2.62 Billion ≈ $82.59 Million |
-0.61pp |
| 2016-12-31 | 7.28% | NT$186.68 Million ≈ $5.88 Million |
NT$2.56 Billion ≈ $80.77 Million |
-0.15pp |
| 2015-12-31 | 7.43% | NT$186.15 Million ≈ $5.86 Million |
NT$2.50 Billion ≈ $78.88 Million |
-0.29pp |
| 2014-12-31 | 7.73% | NT$181.38 Million ≈ $5.71 Million |
NT$2.35 Billion ≈ $73.94 Million |
-2.32pp |
| 2013-12-31 | 10.05% | NT$200.75 Million ≈ $6.32 Million |
NT$2.00 Billion ≈ $62.92 Million |
-10.05pp |
| 2012-12-31 | 20.10% | NT$326.94 Million ≈ $10.30 Million |
NT$1.63 Billion ≈ $51.24 Million |
+2.24pp |
| 2011-12-31 | 17.86% | NT$290.81 Million ≈ $9.16 Million |
NT$1.63 Billion ≈ $51.30 Million |
-3.12pp |
| 2010-12-31 | 20.98% | NT$353.44 Million ≈ $11.14 Million |
NT$1.69 Billion ≈ $53.09 Million |
+1.12pp |
| 2009-12-31 | 19.85% | NT$342.91 Million ≈ $10.80 Million |
NT$1.73 Billion ≈ $54.41 Million |
-0.12pp |
| 2008-12-31 | 19.98% | NT$343.94 Million ≈ $10.84 Million |
NT$1.72 Billion ≈ $54.25 Million |
+6.61pp |
| 2007-12-31 | 13.37% | NT$220.71 Million ≈ $6.95 Million |
NT$1.65 Billion ≈ $52.02 Million |
-3.29pp |
| 2006-12-31 | 16.66% | NT$218.09 Million ≈ $6.87 Million |
NT$1.31 Billion ≈ $41.25 Million |
-- |
About Bioteque
Bioteque Corporation manufactures and sells medical device in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage… Read more